Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
launching new spin-offs, licensing intellectual property to companies, engaging in dynamic partnerships and fostering talent development. VIB has created >40 spin-offs such as Confo Therapeutics, Augustine Tx
-
is situated at the forefront of industrial biotechnology, metabolic engineering and synthetic biology. They focus on the development of standardized, automatable, and generic tools and technologies and
-
cell bank manufacturing: start-up, expansion of different cell types to master and work stock cell culture experiments on request improvement cell bank management system Monthly train newcomers (students
-
development and career growth. The ability to work on high-impact research topics. Full or part-time (80%) appointment as a laboratory technician. A competitive salary and benefits. A
-
of the major contributors to its success. VIB is committed to the growth of the dynamic life sciences cluster in Flanders. The VIB Technologies program - https://vib.be/en/technologies#/ - constitutes
-
translational cancer research. Omics based strategies, such as (epi-)genomics and transcriptomics, are opening unprecedented potential for developing novel precision oncology tools for improved diagnosis
-
of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and centrally located in Europe, Ghent has a scenic yet
-
of researchers. Ghent, the second largest city of Flanders, is a university city and cultural hub. Only half an hour away from Antwerp and Brussels by train, and centrally located in Europe, Ghent has a scenic yet
-
such as the ELIXIR consortium, a European research infrastructure connecting life science resources. The Role A key mission of the VIB Data Core is to develop and maintain infrastructure for the secure
-
, industrial and medical applications and new innovative biotech companies. The Laboratory for Genome Editing and System Genetics at CfM combines development of high-throughput genome editing tools with large